Follow the people · Insider

QP

Quang X. Pham

Insider · Chairman and CEO · CVKD

Quang X. Pham files insider transactions with the SEC as a chairman and ceo of Cadrenal Therapeutics (CVKD). We hold 22 disclosed purchases and sales filed since 13 February 2023, 10 of them in the last 90 days.

  • Files forCVKD
  • Disclosed buys and sells22 in all, 10 in the last 90 days
  • Last disclosure1 July 2026

Positions held

1 post we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 10 February 202329 June 2026Chairman and CEO · Cadrenal Therapeutics (CVKD)46 Form 4 lines · source: SEC Form 4

Everything they disclosed

46 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.